Related references
Note: Only part of the references are listed.Natural History of Pandemic H1N1 2009 Influenza Infection in Healthy Pediatric Outpatients
Michael Hawkes et al.
ACADEMIC PEDIATRICS (2011)
Prospecting the Influenza Hemagglutinin to Develop Universal Vaccines
Ruben O. Donis et al.
CLINICAL INFECTIOUS DISEASES (2011)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
A Computer Simulation of Employee Vaccination to Mitigate an Influenza Epidemic
Bruce Y. Lee et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
Effects of Early Oseltamivir Therapy on Viral Shedding in 2009 Pandemic Influenza A (H1N1) Virus Infection
Li M. Ling et al.
CLINICAL INFECTIOUS DISEASES (2010)
Multimeric-001: BiondVax's universal flu vaccine
Tamar Ben-Yedidia
EXPERT REVIEW OF VACCINES (2010)
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
Gary J. Nabel et al.
NATURE MEDICINE (2010)
Research and development of universal influenza vaccines
Lanying Du et al.
MICROBES AND INFECTION (2010)
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
Taia T. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic
Bruce Y. Lee et al.
VACCINE (2010)
Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles
Bruce Y. Lee et al.
VACCINE (2010)
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
Michael Schotsaert et al.
EXPERT REVIEW OF VACCINES (2009)
Attacking the flu Neutralizing antibodies may lead to 'universal' vaccine
Grace L. Chen et al.
NATURE MEDICINE (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
The timing of influenza vaccination for older adults (65 years and older)
Bruce Y. Lee et al.
VACCINE (2009)
Time lines of infection and disease in human influenza: A review of volunteer challenge studies
Fabrice Carrat et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
The Impact of Influenza on Working Days Lost A Review of the Literature
Martin Keech et al.
PHARMACOECONOMICS (2008)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Live attenuated versus inactivated influenza vaccine in infants and young children
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mapping the antigenic and genetic evolution of influenza virus
DJ Smith et al.
SCIENCE (2004)
Cost-effectiveness of newer treatment strategies for influenza
KJ Smith et al.
AMERICAN JOURNAL OF MEDICINE (2002)
One thousand health-related quality-of-life estimates
TO Tengs et al.
MEDICAL CARE (2000)
Are pharmaceuticals cost-effective? A review of the evidence
PJ Neumann et al.
HEALTH AFFAIRS (2000)
Share Paper
